Mimedx (MDXG) Current Taxes (2015 - 2017)

Mimedx (MDXG) reported Current Taxes of $2.3 million for Q3 2017, up 383.33% sequentially from -$822000.0 in Q2 2017.

Mimedx (MDXG) Current Taxes (2015 - 2017) Analysis & Trends

Mimedx (MDXG) has 3 years of Current Taxes data on file, last reported at $2.3 million in Q3 2017.

  • For the quarter ending Q3 2017, Current Taxes changed N/A year-over-year to $2.3 million; the trailing twelve-month figure through Sep 2017 stood at $2.3 million (changed N/A YoY), and the FY2016 full-year result was $5.6 million, up 8474.63% from the prior year.
  • Current Taxes climbed to $2.3 million in Q3 2017, from -$822000.0 in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $7.8 million in Q1 2017 to a low of -$822000.0 in Q2 2017.
  • A 3-year average of $3.0 million and a median of $2.3 million in 2017 frame the typical range for Current Taxes.
  • Peak annual rise in Current Taxes reached 8474.63% in 2016, while the deepest fall reached 8474.63% in 2016.
  • Tracing MDXG's Current Taxes over 3 years: stood at -$67000.0 in 2015, then surged by 8474.63% to $5.6 million in 2016, then tumbled by 58.49% to $2.3 million in 2017.
  • Business Quant data shows MDXG's Current Taxes at $2.3 million in Q3 2017, -$822000.0 in Q2 2017, and $7.8 million in Q1 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 63.52 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 49.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2017 2.33 Mn
Jun 30, 2017 -822,000.00
Mar 31, 2017 7.84 Mn
Dec 31, 2016 5.61 Mn
Dec 31, 2015 -67,000.00